Products

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DCC3922	orm-10103	Novel sodium/calcium exchanger (NCX) inhibitor More description
DCC3921	Oritavancin	Lipoglycopeptide Antibacterial, acting as a inhibitor of Cytochrome P450 2C19/2C9, and a inducer of Cytochrome P450 3A4/2D6 More description
DCC3920	Org48762-0	Selective p38alpha and p38beta kinase inhibitor More description
DCC3919	Org-29647	CB1 allosteric modulator More description
DCC3918	Org-27759	Negative allosteric modulator at the CB1 receptor More description
DCC3917	Orex-1019	Novel mixed κ/μ receptor antagonist. having therapeutic potential for the treatment of depression and other stress-induced conditions More description
DCC3916	Orcein	Collagen immunostain More description
DCC3915	Orc-13661 Hydrochloride	Novel Potent, Well Tolerated, and Orally Active Protective Agent against Aminoglycoside-Induced Hearing Loss More description
DCC3914	Optoglunam4.1	Novel negative allosteric modulator (NAM) of mGlu4, being isomerized with blue-light/dark cycles with fast relaxation More description
DCC3913	Ophiobolin A	Inhibitor of calmodulin action in calcium regulation More description
DCC3912	Opc-14117	Antioxidant and free radical scavenger, attenuating edema formation, and subsequent tissue damage following cortical contusion More description
DCC3911	Opc-13213	Metabolite of Cilostazol More description
DCC3910	Oopz-23-l(nle)aq	Novel potent inhibitor of protein-protein interactions More description
DCC3909	Ono-ae3-237	Potent, selective, and orally active prostaglandin D2 receptor antagonist More description
DCC3908	Ono-ae-248	Novel selective EP3 receptor agonist More description
DCC3907	Ono-ae2-227	EP(4)-selective antagonist More description
DCC3906	Ono-ae1-329	Novel agonist of the prostaglandin PGE2 receptor EP4 More description
DCC3905	Ono-ae1-259 Lysine	Novel selective EP2 receptor agonist, inducing relaxation of smooth muscle More description
DCC3904	Ono-ae1-259	Highly selective agonist of prostaglandin E2 receptor (EP2) More description
DCC3903	Ono-4310321	Potent, orally available dual CysLT1 and CysLT2 receptor antagonist More description
DCC3902	Ono-4007	Lipid A analog, inducing Th1-type immune response in tumor eradication and restoring nitric oxide production by peritoneal macrophages More description
DCC3901	Ono-3307	Protease inhibitor More description
DCC3900	Ono-2910	Novel enhancer of Schwann cell differentiation for treatment of peripheral nerve disorder More description
DCC3899	Ono12380	Novel non-ATP-competitive inhibitor of BCR-ABL, overriding imatinib resistance More description
DCC3898	Oncrasin-72	Potent analogue of oncrasin-1 with antitumor activity mediated by JNK activation and STAT3 inhibition More description
DCC3897	On012380	Non-ATP-competitive Bcr-Abl inhibitor, potently inhibiting imatinib-resistant Bcr-Abl mutants such as T315I More description
DCC3896	Omdm-188	Novel potent DAGL inhibitor, inhibiting collagen-, but not arachidonic acid-induced aggregation and TxA2 synthesis More description
DCC3895	Olprinone	Phosphodiesterase III inhibitor, augmenting cerebral blood flow by a direct vasodilator effect on cerebral arteries More description
DCC3894	Olmutinib Hydrochloride	Novel Bruton's tyrosine kinase inhibitor, suppressing B cell and monocyte activation and ameliorates arthritis in a mouse model More description
DCC3893	Olfr895-agonist-10	Novel specific agonist of odorant receptor 895 (Olfr895) More description

Products

Customized Consultation X

Your information is safe with us. * Required Fields.